Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
post
The FDA’s CNPV Pilot Is Reshaping Drug Development—Is Your Program Ready to Leverage It?
Read More
post
Ensuring Data Integrity in Pharma: Best Practices for Compliance
Read More
infographic
Common Hurdles Sponsors Face upon a Marketing Application Submission
Read More
post
Cloud and AI in Pharma: Driving Digital Transformation in Pharmaceutical Operations
Read More
Let's move from science to success.
Let’s Talk